Baxter International Inc. (BAX) - Product Pipeline Analysis, 2016 Update

  • ID: 3714922
  • Company Profile
  • Region: Global
  • 62 pages
  • GlobalData
  • Baxter International Inc.
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Hospira, Inc.
  • Johnson & Johnson
  • NxStage Medical, Inc.
  • MORE
Summary

Baxter International Inc. (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. Baxter manufactures its products in over 25 countries and sells them in more than 120 countries. It has wide spread operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Baxter International Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Hospira, Inc.
  • Johnson & Johnson
  • NxStage Medical, Inc.
  • MORE
List of Tables

List of Figures

Baxter International Inc. Company Snapshot

Baxter International Inc. Company Overview

Baxter International Inc. Pipeline Products and Clinical Trials Overview

Baxter International Inc. – Pipeline Analysis Overview

Business Description

Key Facts

Baxter International Inc. - Major Products and Services

Baxter International Inc. Pipeline Products by Development Stage

Baxter International Inc. Clinical Trials by Trial Status

Baxter International Inc. Pipeline Products Overview

Artis Dialysis System

Artis Dialysis System Product Overview

BAXJECT III

BAXJECT III Product Overview

DurADAPT Bioimplant

DurADAPT Bioimplant Product Overview

Hemopatch

Hemopatch Product Overview

Hemopatch Clinical Trial

INDUCTIGRAFT

INDUCTIGRAFT Product Overview

Infusion Pump

Infusion Pump Product Overview

Next Gen ICHD Monitor

Next Gen ICHD Monitor Product Overview

Non PVC CAPD

Non PVC CAPD Product Overview

Non-DEHP Sets

Non-DEHP Sets Product Overview

Ovart 3D Biodegradable Matrix

Ovart 3D Biodegradable Matrix Product Overview

Prismaflex Integrated With Gas Exchange Technology

Prismaflex Integrated With Gas Exchange Technology Product Overview

Prismaflex Integrated With Gas Exchange Technology Clinical Trial

PrismaLung

PrismaLung Product Overview

PrismaLung Clinical Trial

PrisMAX

PrisMAX Product Overview

ProMaxx Microsphere

ProMaxx Microsphere Product Overview

Synthetic Bone Graft - Orthopaedic

Synthetic Bone Graft - Orthopaedic Product Overview

Synthetic Bone Graft - Spinal

Synthetic Bone Graft - Spinal Product Overview

Theralite

Theralite Product Overview

Theranova 400 Dialyzer

Theranova 400 Dialyzer Product Overview

Tisseel Dura

Tisseel Dura Product Overview

URINFO 3000

URINFO 3000 Product Overview

Veritas-Cardiac Application

Veritas-Cardiac Application Product Overview

VIVIA Hemodialysis System

VIVIA Hemodialysis System Product Overview

VIVIA Hemodialysis System Clinical Trial

Baxter International Inc. - Key Competitors

Baxter International Inc. - Key Employees

Baxter International Inc. - Key Employee Biographies

Baxter International Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Baxter International Inc., Recent Developments

Mar 24, 2016: Baxter Completes CE Mark for Expanded Indication of HEMOPATCH, an Innovative Surgical Patch, In European Union

Mar 15, 2016: Baxter Enrolls First Patient in U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System

Feb 02, 2016: Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook

Jan 26, 2016: Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter

Nov 12, 2015: Baxter Completes Capacity Expansion at Halle, Germany Facility to Support BioPharma Solutions’ Oncology Contract Manufacturing Services

Oct 28, 2015: Baxter Names José Almeida Chairman and CEO

Oct 27, 2015: Baxter To Reduce Workforce

Oct 27, 2015: Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance

Oct 21, 2015: Baxter Appoints Michael F. Mahoney to Its Board

Oct 15, 2015: Baxter International expanding operations in Mountain Home

Appendix

Methodology

About us

Contact Us

Disclaimer

List of Tables

Baxter International Inc. Pipeline Products and Clinical Trials Overview

Baxter International Inc. Pipeline Products by Equipment Type

Baxter International Inc. Pipeline Products by Indication

Baxter International Inc. Clinical Trials by Trial Status

Baxter International Inc., Key Facts

Baxter International Inc., Major Products and Services

Baxter International Inc. Number of Pipeline Products by Development Stage

Baxter International Inc. Pipeline Products Summary by Development Stage

Baxter International Inc. Clinical Trials by Trial Status

Baxter International Inc. Clinical Trials Summary

Artis Dialysis System - Product Status

Artis Dialysis System - Product Description

BAXJECT III - Product Status

BAXJECT III - Product Description

DurADAPT Bioimplant - Product Status

DurADAPT Bioimplant - Product Description

Hemopatch - Product Status

Hemopatch - Product Description

Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)

Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant

Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial

Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH

INDUCTIGRAFT - Product Status

INDUCTIGRAFT - Product Description

Infusion Pump - Product Status

Infusion Pump - Product Description

Next Gen ICHD Monitor - Product Status

Next Gen ICHD Monitor - Product Description

Non PVC CAPD - Product Status

Non PVC CAPD - Product Description

Non-DEHP Sets - Product Status

Non-DEHP Sets - Product Description

Ovart 3D Biodegradable Matrix - Product Status

Ovart 3D Biodegradable Matrix - Product Description

Prismaflex Integrated With Gas Exchange Technology - Product Status

Prismaflex Integrated With Gas Exchange Technology - Product Description

Prismaflex Integrated With Gas Exchange Technology - Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

PrismaLung - Product Status

PrismaLung - Product Description

PrismaLung - Extracorporeal CO2 Removal (ECCO2R) with a Renal Replacement Platform (PRISMALUNG) to Enhance Lung Protective Ventilation in Patients with Mild to Moderate Acute Respiratory Distress Syndrome (ARDS)

PrismaLung - Low Flow CO2 Removal Via a Membrane Gas Exchange Device (Prismalung) on a Renal Replacement Platform (Prismaflex) in Hypercapnic, Ventilated Patients Requiring Renal Replacement

PrisMAX - Product Status

PrisMAX - Product Description

ProMaxx Microsphere - Product Status

ProMaxx Microsphere - Product Description

Synthetic Bone Graft - Orthopaedic - Product Status

Synthetic Bone Graft - Orthopaedic - Product Description

Synthetic Bone Graft - Spinal - Product Status

Synthetic Bone Graft - Spinal - Product Description

Theralite - Product Status

Theralite - Product Description

Theranova 400 Dialyzer - Product Status

Theranova 400 Dialyzer - Product Description

Tisseel Dura - Product Status

Tisseel Dura - Product Description

URINFO 3000 - Product Status

URINFO 3000 - Product Description

Veritas-Cardiac Application - Product Status

Veritas-Cardiac Application - Product Description

VIVIA Hemodialysis System - Product Status

VIVIA Hemodialysis System - Product Description

VIVIA Hemodialysis System - A Study of Sleep Patterns in Patients Performing Nocturnal Home Dialysis Utilising the VIVIA System

VIVIA Hemodialysis System - U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System

Baxter International Inc., Key Employees

Baxter International Inc., Key Employee Biographies

Baxter International Inc., Other Locations

Baxter International Inc., Subsidiaries

List of Figures

Baxter International Inc. Pipeline Products by Equipment Type

Baxter International Inc. Pipeline Products by Development Stage

Baxter International Inc. Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Fresenius Medical Care AG & Co. KGaA
NxStage Medical, Inc.
Becton, Dickinson and Company
Johnson & Johnson
Bristol-Myers Squibb Company
Boston Scientific Corporation
Hospira, Inc.
Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll